Kiadis Pharma B.V. (Kiadis)

Oncology Corporate Profile

HQ Location

Entrada 231-234 1114 AA
Amseterdam-Dulvendrecht, The Netherlands,

Company Description

Kiadis Pharma is a clinical stage biopharmaceutical company focused on developing innovative and potentially life-saving therapies for blood cancer patients where pharmacological standard of care is no longer an alternative. The Company's main focus is on the development of a cellular therapeutic that will enable partially mismatched donor stem cell transplants from family members in blood cancer patients, thus making them safe and available as the last potentially life saving option.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
ATIRĀ®th9402 inhibitorVarious cancer typesII

View additional information on product candidates here »


Recent News Headlines

There are no news items to display